Overview

Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase IV Study is to demonstrate the efficacy of CHF5993 (BDP/FF/GB 100/6/12.5 pMDI) on uncontrolled asthma subjects, compared to CHF1535 (BDP/FF 200/6 pMDI)
Phase:
Phase 4
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.